Facebook
Twitter
LinkedIn
Forward
Frontiers In Precision Medicine for Inherited Cancers: From Risk Assessment to Targeted Therapies
Chicago, IL US
April 20, 2018 to April 21, 2018
This activity will provide an interdisciplinary educational forum in which to update state-of-the-art science including novel therapies for inherited cancers, discuss real-world cases, curate interesting pedigrees and prepare case summaries to disseminate new knowledge in translational genomics and evidence-based clinical management of high-risk patients and their family members.
Click on the "Get Started!" tab to register!
This activity is brought to you in partnership with City of Hope.
Target Audience
This activity has been designed for physicians, physician assistants, advanced nurse practitioners, genetic counselors, oncology nurses, and other healthcare professionals currently involved in providing cancer genetics risk assessment services or initiating such services in their healthcare system. Special efforts will be made to educate clinicians practicing in geographically or socioeconomically underserved communities.
Learning Objectives
At the conclusion of this activity, participants will be able to:
- Identify how advanced concepts in genetics, genomics, and next generation sequencing (NGS) technologies can be applied to patient care;
- Recognize advances in the clinical management of patients with inherited cancer syndromes including breast, prostate, gastrointestinal, and hematologic malignancies;
- Discuss integration of novel cancer therapies based on genomic alterations in tumor tissue that may reveal germline mutations such as MLH1 and BRCA mutations into the practice of oncology;
- Describe how to manage cancer patients from high risk families using a globally-informed perspective;
- Discuss emerging models for cancer risk assessment and genetic testing including integration of a polygenic risk score;
- Recognize the ethical, legal, and social implications of genomic testing in healthy populations.
The Gwen, a Luxury Collection Hotel, Chicago
521 North Rush Street
Chicago, IL
60611
United States
SPECIAL ATTENDEE RATES AVAILABLE
Due to the overwhelming popularity of the course, we have sold out of the room block at the host hotel, The Gwen.
The conference however has secured rooms at the Chicago Marriott Downtown Magnificent Mile for the same $185 per night rate.
The conference however has secured rooms at the Chicago Marriott Downtown Magnificent Mile for the same $185 per night rate.
TRAVEL AWARDS
Funds are available for merit- and need-based travel awards for individuals submitting an abstract for poster presentation and/or submission of interesting pedigrees to include in the conference proceedings. Trainees in genetic counseling, nursing or clinical oncology training programs and junior faculty members are encouraged to apply for travel awards. Potential recipients for need-based awards are reviewed for eligibility by the organizing committee based both on:
- His or her representatives as an underrepresented minority health professional, and/or on the applicant’s provision of genetic cancer risk assessment services to underserved and underrepresented minority patient populations
- Statement of limited or no institutional funding for attendance.
ACCESSIBILITY The University of Chicago is committed to providing equal access appropriate to need and circumstances and complies fully with legal requirements of the Americans with Disabilities Act. If you are in need of special accommodation, please contact Polly Grieger-Rossi at 219-465-1115 or via email at polly@meetingachievments.com
The University of Chicago reserves the right to cancel or postpone this conference due to unforeseen circumstances. In the unlikely event this activity must be cancelled or postponed, the registration fee will be refunded; however, The University of Chicago is not responsible for any related costs, charges, or expenses to participants, including fees assessed by airline/travel/lodging agencies.
CONFERENCE CO-DIRECTORS
Olufunmilayo Falusi Olopade, MBBS, FACPWalter L. Palmer Distinguished Service Professor
Director, Center for Clinical Cancer Genetics
Departments of Medicine and Human Genetics
University of Chicago Medicine
Iris Romero, MDAssociate Professor of Obstetrics & Gynecology
Associate Director, Center for Clinical Cancer Genetics
University of Chicago Medicine
Kathy Blazer, EdD, MS, LCGCAssociate Director, Cancer Genetics Education Program
City of Hope National Medical Center
Jeffrey N. Weitzel, MDChief, Clinical Cancer Genetics
Professor of Oncology and Population Sciences
City of Hope National Medical Center
INTERNATIONAL GUEST FACULTY
Roslind Eeles FMedSci, PhD, FRCP, FRCR Professor of Oncogenetics The Institute of Cancer Research Sutton, United Kingdom | William Foulkes, MBBS, PhD, FRSC Director, Program in Cancer Genetics McGill University Montreal, Quebec | Kelly Metcalfe, RN, PhS, FAAN Professor in Cancer Genetics Lawrence S. Bloomberg Faculty of Nursing University of Toronto Toronto, Ontario | Rajiv Sarin, MD Director ACTREC Tata Memorial Centre Mumbai, India |
GUEST FACULTY
Stephen Chanock, MD Director, Division of Cancer Epidemiology and Genetics National Cancer Institute | Susan Hong, MD Associate Professor of Medicine Director of Cancer Survivorship University of Illinois in Chicago | Kutluk Oktay, MD, PhD Professor of OB/GYN and Reproductive Sciences Yale University |
Laurie M. Connors, DNP, APNG, FNP-BC, AGN-BC Assistant Professor School of Nursing/Clinical and Translational Hereditary Cancer Program Vanderbilt University | Marshall Horwitz, MD, PhD Professor & Associate Dean University of Washington | Jodyn Platt, MPH, PhD Assistant Professor of Learning Health Sciences University of Michigan |
Susan Domchek, MD Basser Professor of Oncology University of Pennsylvania | Steven Lipkin, MD, PhD, FACMG Director, Program in Mendelian Genetics Director, Adult and Cancer Genetics Clinic Weill Cornell Medicine | Colin Pritchard, MD, PhD Associate Professor, Laboratory Medicine Director, Genetics and Solid Tumors Laboratory University of Washington |
Montserrat Garcia-Closas, MD, DrPH Deputy Director Division of Cancer Epidemiology and Genetics National Cancer Institute | Arthur Lupia, PhD Hal R Varian Collegiate Professor University of Michigan | Timothy Rebbeck, PhD Professor Harvard Chan School & Dana Farber Cancer Institute |
Michael Hall, MD, MS Director, Gastrointestinal Cancer Risk Assessment Program Associate Professor of Medicine Department of Clinical Genetics Fox Chase Cancer Center | Kara Milliron, MS, CGC Genetic Counselor Hematology/Oncology University of Michigan Comprehensive Cancer Center | Jorge Reis-Filho, MD, PhD Chief, Experimental Pathology Service Member and Attending Pathologist Memorial Sloan Kettering Cancer Center |
| Heather Hampel, MS, LGC Professor of Internal Medicine Associate Director, Division of Human Genetics The Ohio State University | Elias Obeid, MD, MPH Director, Prostate Cancer Risk Assessment Program Assistant Professor Fox Chase Cancer Center | Dawn Sinclair Shapiro Film Director |
THE UNIVERSITY OF CHICAGO FACULTY
Andrea Amico, MD, MA Clinical Associate Hematology/Oncology | Valerie Koch, JD Director, Law & Ethics MacLean Center for Clinical Medical Ethics | Blase Polite, MD, MPP Associate Professor Executive Medical Director for Cancer Accountable Care Hematology/Oncology & Center for Clinical Cancer Genetics |
Jane Churpek, MD Assistant Professor Hematology/Oncology & Center for Clinical Cancer Genetics | Sonia Kupfer, MD Assistant Professor of Medicine Director Gastrointestinal Cancer Risk & Prevention Clinic | Iris Romero, MD Associate Professor Department of Obstetrics & Gynecology Dean for Diversity |
Michael Drazer, MD Fellow Hematology/Oncology | Sarah Nielsen, MS, CGC Cancer Genetic Counselor | Shari Snow, MD Assistant Professor of Obstetrics/Gynecology Section Chief, Gynecology and Minimally Invasive Surgery |
Scott Eggener, MD Associate Professor of Urology – Urologic Oncology and Radiology Urology | Olufunmilayo Olopade, MD, FACP Professor of Medicine Director, Center for Clinical Cancer Genetics | Randy Sweis, MD Instructor of Medicine Hematology/Oncology |
Lucy Godley, MD, PhD Professor of Medicine Hematology/Oncology | Aytekin Oto, MD, MBA Professor of Radiology | Caroline Weipert, MS, CGC Cancer Genetic Counselor |
Neil Hyman, MD, FACS Professor of Surgery Section Chief, Colon and Rectal Surgery | Melody Perpich, MS, CGC Genetic Counselor Pediatric Oncology | Allison West, MD Fellow Hematology/Oncology |
Disclosure Declarations
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. This includes any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months, including financial relationships of a spouse or life partner that could create a conflict of interest. Mechanisms are in place to identify and resolve any potential conflict of interest prior to the start of the activity.
Additionally, The University of Chicago Pritzker School of Medicine requires authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
Physician Credit
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 15 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Genetic Counselor Credit
The National Society of Genetic Counselors (NSGC) has authorized University of Chicago Pritzker School of Medicine to offer up to 1.5 CEUs or 15.0 Category 1 contact hours for the activity 7th Annual Clinical Cancer Genetics and Genomics Conference. The American Board of Genetic Counseling (ABGC) will accept CEUs earned at this program for the purposes of genetic counselor certification and recertification.
Other Healthcare Professions Credit
Nurses and other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.
Nurses and other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.
REGISTRATION: Select your profession type and click "Register Now!" Simply follow the prompts to complete your registration.
For more information, view the brochure here.
For more information, view the brochure here.
Early Bird Rate: Use the EARLY BIRD CODE listed with YOUR PROFESSION TYPE to access the early bird rate.
Early Bird ends March 16, 2018!
| Profession Type | Early Bird | Early Bird Code | Regular |
|---|---|---|---|
| Physicians | $495 | EXPIRED | $595 |
| Genetic Counselors *$25 additional fee for Genetic Counseling CEUs | $300 | EXPIRED | $345 |
| Other Healthcare Professionals | $300 | EXPIRED | $345 |
Resident/Fellow - Letter of Verification Required Send here | $195 | EXPIRED | $275 |
CCGCoP members: To receive a $50 per person discount - please enter CCGC50 to receieve the discount.
Genetic Counselors: Select the "Genetic Counseling CEU Fee" in addition to your registration fee if you would like to claim Genetic Counseling CEUs.
Genetic Counselors: Select the "Genetic Counseling CEU Fee" in addition to your registration fee if you would like to claim Genetic Counseling CEUs.
CLAIMING CREDIT: At the end of the course, the credit claiming process will unlock. Return to this page and simply click on "Complete Activity" to proceed.
CANCELLATION POLICY If you cancel your participation in this conference, your registration fee less a $100 administrative fee will be refunded when written notification is received by March 20, 2018. No refunds will be made after March 20, 2018.
Please Note: We are close to reaching capacity.
At capacity, registration will close and the waitlist will open to which you may add yourself.
However, you must be logged in or have created an account to do so.
Please login or create an account to proceed.